Open Orphan #ORPH – Result of Rule 15 Offer and Total Voting Rights
Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs , announces, further to its announcement of 7 January 2020, the results of the Rule 15 Offer previously issued to the holders of options in hVIVO. Under the Rule 15 offer (the “Rule 15 Offer”), 4 hVIVO option holders […]
Built to sell – can dealmaker Cathal Friel build (and sell) a £80m company in two years?
by Sean Keyes | Financial Correspondant Serial dealmaker Cathal Friel has an audacious plan: build and sell a pharma services company in two years. It could fetch as much as £100 million. What exactly is his plan? And will it work? On the cover of the fifth edition of Dr John Oxford’s book Human Virology […]
Open Orphan #ORPH presents at ShareSoc Growth Company Seminar, Manchester
Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, and has Europe’s only 24 bedroom quarantine clinic with onsite virology lab in Queen Mary’s Hospital London, is pleased to announce that the Company will […]
Open Orphan (ORPH) Appoints Professor Oxford as Chair of Advisory Board, with initial focus to help guide Open Orphan in the provision of solutions to Coronavirus outbreak
Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, and has Europe’s only 24 bedroom quarantine clinic with onsite virology lab in Queen Mary’s Hospital London, is pleased to announce the appointment of Professor […]
Open Orphan #ORPH – Appointment of Group Chief Financial Officer
Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, and has Europe’s only 24 bedroom quarantine clinic with onsite virology lab in Queen Mary’s Hospital London, is pleased to announce the appointment […]
Vox Markets Q&A with Open Orphan #ORPH Exec Chairman Cathal Friel
Open Orphan #ORPH Exec Chairman Cathal Friel discusses the completion of the hVIVO acquisition and provides an update on activities with Abraham Darwyne at Vox Markets.
Open Orphan #ORPH – Value the Markets Webinar
Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce that the Company will be hosting a webinar for investors at 7pm on Tuesday 11th February. For those wishing to […]
LSE interview – Cathal Friel refocuses Open Orphan #ORPH as he raises 5m and buys virology specialist hVIVO
In a wide-ranging interview with London South East, Open Orphan Executive Chairman Cathal Friel outlines his vision for the business and explains how the combined talents of Open Orphan, hVivo and Venn Life Sciences will create a soon to be profitable pharmaceutical services one-stop shop. Friel says this acquisition is the last however, as he […]
Open Orphan #ORPH presents at Shares Growth and Invention Forum, London
Open Orphan, the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce that the Company will be attending and presenting at the Shares Growth and Invention Forum on February 11, 2020 at Business Design […]
BRR Media – Open Orphan #ORPH introduces Professor John Oxford
BRR Media introduces Open Orphan’s Professor John Oxford, consultant to the company and Virology expert. He discusses virology, and looks at recent virus epidemics, including influenza, AIDS, SARS and now Coronavirus. He explains how the hHIVO quarantine unit could play a key role in defeating Coronavirus…”This group (Open Orphan) is perfectly positioned, probably like no […]